US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
BIOSENTA Inc (ZRO) 銘柄情報

BIOSENTA Inc (ZRO)

0.045

-0.015

(-25.00%)

終了 6月9日 5:00AM

BIOSENTA Inc (ZRO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.045

( -25.00% )

買値

0.045

売値

0.075

出来高

5,000

0.045 日の範囲 0.06

0.045 52 週間の範囲 0.17

時価総額

前日終値

0.06

始値

0.06

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 19,462

発行済株式数

36,648,708

配当利回り

PER

-0.84

1 株当たり利益 (EPS)

-0.07

歳入

3.9k

純利益

-2.39M

Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, and fungi. It also manufactures and distributes Tri-Filler, a... Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was incorporated in 1986 and is based in Toronto, Canada. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Household & Personal

ウェブサイト

www.biosenta.com

本社

Toronto, Canada

設立

1986

BIOSENTA Inc is listed in the Consumer Staples sector of the Canadian Securities Exchange with ticker ZRO. The last closing price for BIOSENTA was $0.06. Over the last year, BIOSENTA shares have traded in a share price range of $ 0.045 to $ 0.17.

BIOSENTA currently has 36,648,708 shares in issue. The market capitalisation of BIOSENTA is $1.65 million. BIOSENTA has a price to earnings ratio (PE ratio) of -0.84.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.015	-25	0.06	0.06	0.045	2340	0.06	CS
4	-0.015	-25	0.06	0.06	0.045	2305	0.06	CS
12	-0.035	-43.75	0.08	0.08	0.045	6070	0.05624609	CS
26	-0.075	-62.5	0.12	0.13	0.045	4756	0.07120924	CS
52	-0.1	-68.9655172414	0.145	0.17	0.045	3545	0.08813666	CS
156	-0.335	-88.1578947368	0.38	0.89	0.045	4005	0.16075319	CS
260	-0.435	-90.625	0.48	0.89	0.045	3395	0.25159701	CS

ZRO - Frequently Asked Questions (FAQ)

What is the current BIOSENTA Inc share price?

The current share price of BIOSENTA Inc is $ 0.045

How many BIOSENTA Inc shares are in issue?

BIOSENTA Inc has 36,648,708 shares in issue

What is the market cap of BIOSENTA Inc?

The market capitalisation of BIOSENTA Inc is CAD 1.65M

What is the 1 year trading range for BIOSENTA Inc share price?

BIOSENTA Inc has traded in the range of $ 0.045 to $ 0.17 during the past year

What is the PE ratio of BIOSENTA Inc?

The price to earnings ratio of BIOSENTA Inc is -0.84

What is the cash to sales ratio of BIOSENTA Inc?

The cash to sales ratio of BIOSENTA Inc is 564.26

What is the registered address of BIOSENTA Inc?

The registered address for BIOSENTA Inc is 18 Wynford Drive, Toronto, Ontario, M3C 3S2

What is the BIOSENTA Inc website address?

The website address for BIOSENTA Inc is www.biosenta.com

Which industry sector does BIOSENTA Inc operate in?

BIOSENTA Inc operates in the Consumer Products - Household & Personal sector

Galzus Research

Galzus Research 5分前

I believe my point has been very explicit.

The idea that keeps getting raised here is that DCVax, some version of it, has a shot at tissue-agnostic approval. And that this might even be a plausible reason for the "delay" with the MHRA.

The point I keep raising is that

ollik78

ollik78 7分前

CHAI 10+ 🚬📈🧐

brazen22

brazen22 8分前

I think calling leukapheresis capacity and adding Dr. Jenkins “ongoing operations” minimizes the point.

If they were merely ordinary business items, why PR them at all?

The obvious reason is that NWBO wanted investors to understand operational readiness and progress tow

Z06 MAN

Z06 MAN 11分前

What happened to the 10 ton goal for May? Just another false statement. They haven’t produced enough for the 1.5 tons of finished product. At this rate, the end of 2026 might see sales. More Patience required….

i_like_bb_stock

i_like_bb_stock 13分前

$BTOG wow RW filing they usually move on this
https://www.sec.gov/Archives/edgar/data/1735556/000110465926071537/tm2522888d5_rw.htm

i_like_bb_stock

i_like_bb_stock 13分前

$BTOG wow RW filing they usually move on this
https://www.sec.gov/Archives/edgar/data/1735556/000110465926071537/tm2522888d5_rw.htm

abrooklyn

abrooklyn 13分前

https://medium.com/codetech/tell-me-more-about-core-tmmac-becomes-an-official-core-community-education-channel-b825e9b8e2a6

Buckey

Buckey 13分前

More pure insanity Premarket some on no news

also add in stocks just mentioning AI

we are in a bubble. The hype is overwhelming on AI SpaceEx etc. Been there done that.

funnytimes2

funnytimes2 14分前

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Company Continues Delivering on Aggressive 2026 Expansion Strategy as Production Scale Reaches New Heights

ANN ARBOR,

AMOTE1

AMOTE1 16分前

“We said 2026 would be a year of aggressive expansion and accelerating production, and our team continues to execute on that commitment,” said Kim Thompson, CEO and Founder of Kraig Labs. “Nearly 2.5 metric tons from a single production cycle is a first for industry and a world record. Each producti

John Doe 2024

John Doe 2024 16分前

Taking a toxic loan from Auctus and giving it to XTI and diluting hundreds of millions of shares to pay it back is why pps is a measly 2 cents not because of manipulation!

Madguppy

Madguppy 19分前

May be a post to check out in the short term.

https://x.com/scottmi65383320/status/2064163222131995113?s=20

Monksdream

Monksdream 20分前

TOP 15
https://www.advfn.com/markets/nasdaq/premarket

RIGATONI

RIGATONI 21分前

Dip here into the .27s, may be a nice buy-back area ~Rig

AMOTE1

AMOTE1 21分前

https://www.kraiglabs.com/kraig-biocraft-laboratories-sets-new-all-time-production-record-delivering-nearly-2-5-metric-tons-of-recombinant-spider-silk-in-single-production-cycle/

Jake731

Jake731 23分前

Good morning all.

TPTW-EM……!!!!!!!

VuMe Live 😎😎😎

jopo

Seem's, Webull is working good for you.

RIGATONI

RIGATONI 23分前

Good morning! ~Rig

jimmybob

jimmybob 25分前

$RDDT with some pre-market love

US Market News

US Market News 26分前

Fresh Del Monte Produce Inc. Announces Name Change to Del Monte Corporation and NYSE Ticker Symbol Change to “DMC”June 9, 2026 6:30 AM
Business Wire Reflects the Company's Expanded Role as Global Owner of the Del Monte® Brand; Ticker Symbol Change Effective Jun

US Market News

US Market News 26分前

Four-Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long-Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)June 9, 2026 6:30 AM
Business Wire Persistently Low Target Lesion Failure and No New Cardiac-Rel

US Market News

US Market News 26分前

Uxin to Report First Quarter 2026 Financial Results on June 16, 2026June 9, 2026 6:30 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 9, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq:

SovereignNinja5

SovereignNinja5 26分前

Vascepa still holds roughly 50% of the total icosapent ethyl market even with zero sales reps on the ground and after losing preferred status at CVS. That’s not a dead product — that’s a product that’s been surviving on brand loyalty and prescriber habit while the company was busy firing its commerc

US Market News

US Market News 26分前

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in AlaskaJune 9, 2026 6:30 AM
PR Newswire (US) class="legendSpanClass"VANCOUVER, BC, class="legendSpanClass"June 9, 2026 /PRNewswire/

WisdomTree Hedged Commod...

BlackRock iShares FTSE M...

Fuyo General Lease (PK)

Franklin Templeton ICAV ...

DJ Global LargeCap Total...

4.500% Rst Subord Nts 11...

Metals Australia

State Street SPDR Portfo...

Australia and New Zealan...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。